Lennart Tonneijck
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials.
Journal: Journal of diabetes and its complications
Published: October 18, 2021
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.
Journal: Diabetes, obesity & metabolism
Published: May 19, 2021
Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function.
Journal: American journal of physiology. Renal physiology
Published: April 26, 2021
The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes.
Journal: Scientific reports
Published: March 19, 2021
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial.
Journal: Diabetes, obesity & metabolism
Published: March 25, 2020
High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients.
Journal: Pancreas
Published: December 20, 2019
Plasma uric acid and renal haemodynamics in type 2 diabetes patients.
Journal: Nephrology (Carlton, Vic.)
Published: July 23, 2019
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
Journal: Kidney international
Published: July 10, 2019
Renal sinus fat and renal hemodynamics: a cross-sectional analysis.
Journal: Magma (New York, N.Y.)
Published: March 15, 2019
Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial.
Journal: Diabetes research and clinical practice
Published: February 08, 2019
Last Updated: 09/26/2026